This international meeting continues to be the ideal forum for drug discovery and chemical biology professionals to discuss the frontline of chemical biology, drug discovery and translational medicine research.
This year, the programme will focus on the use of more predictive model systems throughout the discovery process, from early primary screening and moving towards preclinical and clinical studies including:
Who should attend? The meeting will gather scientists and managers from industry and academia interested in the field of drug discovery and chemical biology. It will also provide an excellent opportunity to interact with vendors of services, reagents and instruments targeting this field of research and development.
SLAS is proud to be a valued community for more than 20,000 life sciences discovery and technology professionals from across the globe, including scientists, innovators, researchers, academics and students, engineers, informatics specialists, and business leaders. 5,000 members are located in Europe. Two-minute video: The SLAS Community.
The SLAS Europe support system enables laboratory science and technology professionals to enjoy increased access to our full menu of networking programs, educational opportunities, products and services in their own region.